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put together. The robustness was assessed by applying 
Hounsfield unit (HU) perturbations of 3.5% and isocenter 
shifts of 5mm. Single beam optimisation (SBO) using a 
horizontal beam line was used when possible. PTV constraints 
were D2% < 107%, D98% > 90% and V95% > 95% (ICRU). Limits 
to organs-at-risk (OAR) were the dose-surface area for the 
skin A60Gy (RBE) < 20cm2 [2], maximum dose to the bones 
DRBE, 2% < 60 Gy (RBE), maximum dose to the nerves and 
vessels DRBE, 2% < 70 Gy (RBE). 
[1] Haas et al 2012 IJROBP 84: 572-580 
[2] Sugahara et al 2012 RadiotherOncol 105: 226-231 
 
Results: Patients with field lengths < 18cm (PTV volumes: 
164-659 cm3) could be treated with SBO using 2 horizontal 
beams and table rotation. In the nominal plan, PTVV95% 
ranged from 96.3-98.9%. SkinA60Gy (RBE) was 10±7.5cm2. 
Treatment plans were robust against HU perturbations and 
5mm shifts in sup-inf and right-left direction with V95 never 
dropping below 93%. D2% and D98% of the PTV and OAR doses 
never exceeded the limits. Shifts of 5mm in ant-post 
direction caused severe underdosage in the PTV down to 
V95% of 68%. Robust optimisation in ant-post direction could 
increase these values up to 91%.  
For larger PTVs (420 cm3-2240cm3) field lengths ranged from 
25-34 cm. The length of the field overlapping region 
essentially influenced the robustness of the treatment plans. 
Isocenter shifts of 5mm to each other or apart resulted in a 
PTVD2% change of 7% for an overlap >6cm increasing up to 
15% for ≤ 6cm (Figure 1). 
 
 
Conclusion: Robust treatment plans could be achieved for 
ESTS patients employing a horizontal beam line only. Before 
clinical implementation, dosimetric monitoring of skin doses 
should be performed to verify the calculated values. If field 
matching is needed a maximal overlap of the matching fields 
should be guaranteed to avoid hot or cold spots in the 
overlapping area. 
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Purpose or Objective: During the last couple of years, 
volumetric modulated arc therapy (VMAT) is a treatment 
modality of increasing interest in radiation oncology. Thereby 
VMAT utilizes dynamic gantry rotation, dynamic MLC and 
varying dose rate. However, in addition the collimator angle 
could be changed dynamically, thus, increasing the degrees 
of freedom for the optimization, which might lead to 
improved dose distributions. This work investigates the 
feasibility of VMAT optimization including a dynamic 
collimator rotation. 
 
Material and Methods: In this work a 20 x 20 x 20 cm^3 
homogeneous water phantom with a cigar shaped target 
volume and a close-by spherical shaped critical structure was 
used. By means of the Eclipse Research Scripting a 
predefined collimator rotation was included to a partial arc 
in a not yet optimized treatment plan. For this purpose a 
different collimator angle was assigned for each dicom 
control point. Thereby the collimator rotation takes into 
account the physical limitations for the dose delivery. This 
treatment plan was then imported into the treatment 
planning system Eclipse using the Eclipse Research Scripting 
interface. Then the VMAT optimization was performed 
applying the PRO3 optimization algorithm in a research 
version of Eclipse. For the dose calculation of the optimized 
treatment plan the Swiss Monte Carlo Plan (SMCP) was used 
[1]. Similarly, a dose distribution was determined using a 
static collimator angle as typically applied in conventional 
VMAT applications. The resulting DVHs for the target and the 
critical structure were compared for the treatment plans. 
 
Results: The optimization of a VMAT treatment plan with a 
dynamically rotating collimator was successfully performed. 
The comparison of the DVHs for the target volume showed a 
slight improvement of the coverage as well as the dose 
homogeneity for the treatment plan using dynamic collimator 
rotation compared to the plan applying a fixed collimator 
angle. Additionally, the dose to the critical structure could 
be reduced when using the dynamic collimator rotation 
instead of a fixed collimator angle. 
 
Conclusion: The usage of a dynamic collimator rotation for 
VMAT is feasible and has the potential to improve the dose 
distribution for the target while reducing the dose to critical 
structures. This work was supported by Varian Medical 
Systems. 
References: 
[1] M.K. Fix, P. Manser, D. Frei, W. Volken, R. Mini, E.J. 
Born, An efficient framework for photon Monte Carlo 
treatment planning, Phys. Med. Biol., 52:N425-437, 2007. 
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Purpose or Objective: Several studies suggest that IMRT can 
reduce toxicity in rectal cancer patients. A preconfigured 
plan model might improve daily clinical activity outcomes. 
Aim of this study was the evaluation of the performances of 
RapidPlan®Varian Medical System, a commercial model-
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based optimization engine, in locally advanced rectal cancer 
(LARC) IMRT plans in terms of planning target volume (PTV) 
coverage and Organs at Risk (OaRs) sparing. 
 
Material and Methods: Between January 2014 and March 
2014, 60 previously irradiated patients with LARC were 
retrospectively recruited: 40 IMRT plans were selected to 
configurate the Dose Volume Histogram (DVH) model and to 
train it. The remaining 20 were firstly manually optimized by 
2 medical physicists and then used to validate the model as 
benchmark plans (BP). OaRs constrains followed Quantec 
guidelines. Three model based on different PTV objectives 
have been generated: DVH model 95-105%, DVH model 98-
105% and DVH model 98-103% where more than 95%, 98% and 
98% of the PTV received more than 95% of the prescription 
dose and less than 5%, 5% and 3% of the PTV received more 
than 105% of the prescription dose, respectively. The 
performances of automated plans (one series for each model) 
vs BP were statistically compared using Wilcoxon signed-rank 
test, for PTV V95 and V105, hot spot out of PTV (HToPTV), 
bladder mean dose (BmD) and maximum dose (BMD), bowel 
mean dose (BomD) and V45 (BV45). Two expert 
radiotherapists (observer1 and observer2) clinically validated 
in double blind the IMRT plans. 
 
Results: A statistical significant improvement was observed 
for the following dosimetric parameters: HToPTV (for DVH 
model 98-105 and DVH model 98-103 plans, p=0.002 and 
p=0.005, respectively); BmD (DVH model 95-105 and DVH 
model 98-105 plans, p= 0.01 and p= 0.03, respectively). A 
statistically significant disadvantage in terms of BMD was 
observed for DVH model 98-103 and DVH model 98-105 
(p=0.02 and p= 0.05, respectively). No statistical differences 
were recorded in term of BV45 and BomD and PTV V95 and 
V105. (TABLE 1) At a clinical validation, the two observers 
most frequently chose the test plans optimized from DVH 
model 98-103% (34 times versus 26 times of the BP). 
 
 
 
Conclusion: The results of this study show dosimetric and 
clinical improvements of IMRT plans optimized by knowledge-
based planning models compared to BP. The data suggest and 
encourage the application of this engine into daily clinical 
practice. 
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Purpose or Objective: To assess the performance of coplanar 
and non-coplanar beam angular optimization for two 
different algorithms integrated in a fully automated 
multicriterial plan generation system for nasopharyngeal 
tumour cases. 
Material and Methods: A retrospective study including data 
of 40 nasopharyngeal cases was performed. In each plan, the 
primary tumour, up to 3 adenopathies, and ipsilateral and 
contralateral lymph nodes were irradiated with doses of 70 
Gy, 59.4 Gy and/or 54 Gy delivered in 33 fractions, 
respectively. A ‘wish-list’ based on hard constraints and 
prioritized objectives for the target volumes and the organs 
at risk was tailored according to the local clinical practice. 
Seven coplanar equidistant angles (E7) were used in the 
standard plan. For each patient, this IMRT plan was compared 
to coplanar and non-coplanar IMRT plans with 5, 7 and 9 
beam angles, optimized with a multicriterial beam angle 
optimization algorithm (A5, A7, A9), and an in-house 
derivative-free optimization algorithm (B5, B7, B9). Dose 
distribution quality for each plan was assessed through DVH 
analysis and a dose metrics weighted sum approach. 
 
Results: Globally all generated plans presented a good dose 
distribution. On average, similar results have been obtained 
for both coplanar beam angle optimization algorithms. For 
non-coplanar beams, the best results were obtained with 
algorithm B. When compared with B coplanar cases, on 
average, slightly better results were achieved with non-
coplanar plans for all number of beams (B5, B7 and B9). For 
algorithm A, on average, no relevant improvement was 
obtained with the non-coplanar optimization compared with 
the coplanar plans or the E7 plans. Despite these average 
results, in particular clinical cases, appreciable differences 
concerning organ sparing could be found. Up to 9 Gy 
difference in parotid sparing was achieved both with B9 and 
A9 coplanar plans when compared with E7 plans. This 
maximum dose sparing rose to 22 Gy when non-coplanar 
beams were considered. For the spinal cord, a maximum dose 
difference of 6 Gy was found between A9 and B9 both for 
coplanar and non-coplanar beam geometries. In the chiasm, 
B9 gave up to 5 Gy less than A9 in coplanar beams but this 
dose sparing for B9 rose to 35Gy for the non-coplanar 
geometry. For ears B5 non-coplanar plans achieved a better 
performance than A9 coplanar plans in 66% of the cases. For 
this structure, up to 15 Gy differences were found between 
B5 non-coplanar and A9 coplanar plans. 
 
Conclusion: Using a dose metric weight sum approach two 
beam angle optimization algorithms were compared in a 
faster and systematic way. On average, both algorithms 
performed well for the tested clinical cases. However, the 
different beam angle optimization strategies intrinsic to each 
of the algorithms revealed to favour algorithm B for non-
coplanar beam geometries while for coplanar beams no 
relevant differences were found between algorithms A and B. 
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Purpose or Objective: A Multicriteria Optimization (MCO) 
algorithm for VMAT planning that can generate Pareto-
optimal plans was recently implemented in the RayStation 
TPS. The user can generate a plan database with a defined 
number of Pareto-optimal plans and can explore tradeoffs 
between different objectives in real time. This study 
investigates MCO for semi-automated VMAT planning for 
irradiation of prostate including pelvic lymph nodes. 
 
Material and Methods: CT datasets of ten patients with high 
risk prostate cancer were used for this study. For each 
patient, a two stage VMAT plan (6 MV Elekta Agility linac) 
was generated, consisting of a stage 1 plan delivering 50.4 Gy 
to the lymph nodes (PTV-LN) and 56 Gy to the prostate (PTV-
P) in a simultaneous integrated boost (SIB) in 28 fractions 
with a dual arc and a stage 2 plan delivering 22 Gy to the 
PTV-P in 11 fractions with a partial arc. The separation of the 
